Emergency Care Applied Research Network investigators. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020 Apr 11;395(10231):1217-1224. \[[PMC free article: PMC7241415](/pmc/articles/PMC7241415/)\] \[[PubMed: 32203691](https://pubmed.ncbi.nlm.nih.gov/32203691)\] 35. Rossetti AO, Milligan TA, Vulliémoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011 Feb;14(1):4-10. \[[PubMed: 20878265](https://pubmed.ncbi.nlm.nih.gov/20878265)\] 36. Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011 Oct;52 Suppl 8:53-6. \[[PubMed: 21967364](https://pubmed.ncbi.nlm.nih.gov/21967364)\] 37. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013 Feb;12(2):157-65. \[[PMC free article: PMC3563251](/pmc/articles/PMC3563251/)\] \[[PubMed: 23290630](https://pubmed.ncbi.nlm.nih.gov/23290630)\] 38. Sakuma H, Awaya Y, Shiomi M, Yamanouchi H, Takahashi Y, Saito Y, Sugai K, Sasaki M. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand. 2010 Apr;121(4):251-6. \[[PubMed: 20028339](https://pubmed.ncbi.nlm.nih.gov/20028339)\] 39. Laswell EM, Chambers KD, Whitsel DR, Poudel K. New-onset refractory status epilepticus in an adult with an atypical presentation of cat-scratch disease: successful treatment with high-dose corticosteroids. Pharmacotherapy. 2015 Jun;35(6):e106-10. \[[PubMed: 26044784](https://pubmed.ncbi.nlm.nih.gov/26044784)\] 40. Kenney-Jung DL, Vezzani A, Kahoud RJ, LaFrance-Corey RG, Ho ML, Muskardin TW, Wirrell EC, Howe CL, Payne ET. Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol. 2016 Dec;80(6):939-945. \[[PMC free article: PMC5225882](/pmc/articles/PMC5225882/)\] \[[PubMed: 27770579](https://pubmed.ncbi.nlm.nih.gov/27770579)\] 41. Westbrook C, Subramaniam T, Seagren RM, Tarula E, Co D, Furstenberg-Knauff M, Wallace A, Hsu D, Payne E. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman. WMJ. 2019 Oct;118(3):135-139. \[[PMC free article: PMC7082129](/pmc/articles/PMC7082129/)\] \[[PubMed: 31682750](https://pubmed.ncbi.nlm.nih.gov/31682750)\] 42. Lin JJ, Lin KL, Hsia SH, Wang HS., CHEESE Study Group. Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr Neurol. 2012 Dec;47(6):448-50. \[[PubMed: 23127267](https://pubmed.ncbi.nlm.nih.gov/23127267)\] 43. Gofshteyn JS, Wilfong A, Devinsky O, Bluvstein J, Charuta J, Ciliberto MA, Laux L, Marsh ED. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases. J Child Neurol. 2017 Jan;32(1):35-40. \[[PubMed: 27655472](https://pubmed.ncbi.nlm.nih.gov/27655472)\] 44. Nabbout R, Mazzuca M, Hubert P, Peudennier S, Allaire C, Flurin V, Aberastury M, Silva W, Dulac O. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced